PA
HTGC icon

PharVision Advisers’s Hercules Capital HTGC Stock Holding History

PharVision Advisers’s Portfolio HTGC Stock Details HTGC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-11,918
Closed -$224K – 353
2025
Q4 		$224K Buy
+11,918
New +$215K 0.11% 461
2025
Q1 		– Sell
-10,111
Closed -$203K – 388
2024
Q4 		$203K Buy
+10,111
New +$197K 0.17% 297

Other funds holding HTGC

SIS
Sound Income Strategies Ft Lauderdale, Florida $2.07B AUM 4.33% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
MC
Muzinich & Co New York $286M AUM 21.05% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

PharVision Advisers's HTGC Position: Q1 2026 in Review

PharVision Advisers sold out of Hercules Capital (HTGC) in Q1 2026, closing a stake of 11,918 shares — an estimated $224K sold.

PharVision Advisers first reported a position in HTGC in Q4 2024 and held it in 2 quarters. The position peaked at $224K in Q4 2025. 349 funds tracked by Wall St. Rank hold HTGC as of Q1 2026.

  • PharVision Advisers reported no remaining Hercules Capital position as of Q1 2026 after selling out during the quarter.
  • PharVision Advisers sold 11,918 Hercules Capital shares in Q1 2026, an estimated $224K.
  • PharVision Advisers first reported a position in Hercules Capital in Q4 2024 and held it in 2 quarters.
  • PharVision Advisers's Hercules Capital position peaked at $224K in Q4 2025.
  • 349 funds tracked by Wall St. Rank held Hercules Capital as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.